trending Market Intelligence /marketintelligence/en/news-insights/trending/vxOVc-6KWWCje9AUXZpI_Q2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Charles River acquires biological services provider HemaCare for $380M

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Charles River acquires biological services provider HemaCare for $380M

Charles River Laboratories International Inc. completed the acquisition of biological services provider HemaCare Corp. for about $380 million in cash, equivalent to $25.40 per HemaCare share.

HemaCare produces human cellular products, which support medical research and drug development, for use in the cell therapy market. Charles River said the acquisition will complement its portfolio of early-stage research and manufacturing products and increase revenue by at least 30% annually over the next five years.